AMNEAL Biosciences has launched a new generic product in the US healthcare institutional market, with the release of meropenem for injection USP (I.V.), a generic equivalent to intravenous antibiotic Merrem.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Oct 16
